Is a complete TPEX/1796 research report available?

No complete published report is available for tpex/1796 (TPEX/1796) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/1796 stock profile: metrics, valuation and analysis

Market cap	1.2B
Revenue (ttm)	664.9M
Net income (ttm)	17.1M
EPS (ttm)	NT$0.41
Shares out	41.5M
P/E (trailing)	70.8x
Dividend	NT$0.70 (2.32%)
Volume	12,001
Beta	0.07

All TPEX/1796 indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

TWD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	144
Enterprise value	TWD 1.2B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	40.55
Isin	TW0001796001
Last refreshed	2026-09-12
Market cap	TWD 1.2B
Price	TWD 29.05
Price currency	TWD
Rev Per Employee	4,617,604.17x
Sector	Healthcare
Sector PE	88.31
Sector PE Fwd	27.72
Sic	2834
Symbol	tpex/1796
Website	https://www.geneferm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.42%
EV Earnings	72.33x
EV/EBIT	62.55x
EV/EBITDA	13.28x
EV/FCF	15.76x
EV/Sales	1.86x
FCF yield	6.51%
P/B ratio	1.54x
P/E ratio	70.8x
P/S ratio	1.81x
PE Ratio10 Y	65.63x
PE Ratio3 Y	68.49x
PE Ratio5 Y	49.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.97%
EBITDA Margin	12.89%
FCF margin	11.78%
Gross margin	25.71%
Gross Profit	TWD 170.9M
Gross Profit Growth	20.36%
Gross Profit Growth Q	-11.95%
Gross Profit Growth3 Y	-14.16%
Gross Profit Growth5 Y	1.41%
Net Income	TWD 17.1M
Net Income Growth Q	152.9%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	-47.83%
Net Income Growth5 Y	-11.79%
Pretax Margin	3.16%
Profit Margin	2.57%
Profit Per Employee	TWD 118,563
Profitable Quarters	TWD 1
Profitable Years	1
ROA	0.98
Roa5y	3.6
ROCE	1.83
ROE	2.16
Roe5y	7.45
ROIC	1.96
Roic5y	7.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.98%
Cagr1y	-52.85%
Cagr3y	-30.33%
Cagr5y	-0.41%
Div CAGR3	-22.43%
Div CAGR5	53.16%
EPS Growth Q	150
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	-47.85
EPS Growth5 Y	-15.07
FCF Growth Qo Q	50.3%
OCF Growth	365.68%
OCF Growth Q	1,703.18%
OCF Growth Qo Q	67.8%
OCF Growth10 Y	-1.69%
OCF Growth3 Y	-11.68%
OCF Growth5 Y	6.8%
Revenue Growth	7.05x
Revenue Growth Q	0.64x
Revenue Growth Qo Q	10.27x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.02x
Revenue Growth5 Y	9.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.53
Assets	TWD 1.3B
Cash	TWD 282M
Current Assets	TWD 586.9M
Current Liabilities	TWD 188M
Debt	TWD 312.4M
Debt EBITDA	TWD 3.36
Debt Equity	TWD 0.4
Debt FCF	TWD 3.99
Equity	TWD 783.9M
Interest Coverage	3.19
Liabilities	TWD 482.3M
Long Term Assets	TWD 679.3M
Long Term Liabilities	TWD 294.3M
Net Cash	TWD -30.4M
Net Cash By Market Cap	TWD -2.53
Net Debt EBITDA	TWD 0.36
Net Debt Equity	TWD 0.04
Net Debt FCF	TWD 0.39
Tangible Book Value	TWD 783M
Tangible Book Value Per Share	TWD 18.89
WACC	4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.12
Inventory Turnover	2.57
Net Working Capital	TWD 156.9M
Quick ratio	1.92
Working Capital	TWD 398.8M
Working Capital Turnover	TWD 1.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.1%
Dividend Growth	0%
Dividend Growth Years	3%
Dividend per share	TWD 0.7
Dividend Years	1
Dividend Yield	2.32%
Ex Div Date	2026-07-14
Last Dividend	TWD 0.7

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-51.48%
1Y total return	-52.82%
200-day SMA	38.72
3Y total return	-66.19%
50-day SMA	30.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-2.03%
All Time High	158.5
All Time High Change	-81.67%
All Time High Date	2023-05-15
All Time Low	18.5
All Time Low Change	57.03%
All Time Low Date	2020-03-23
ATR	0.63
Beta	0.07
Beta1y	0.15
Beta2y	0.27
Ch YTD	-39.79
High	29.75
High52	63.5
High52 Date	2025-09-11
High52ch	-54.54%
Low	29.05
Low52	28.25
Low52 Date	2026-07-29
Low52ch	2.83%
Ma50ch	-6.06%
Price vs 200-day SMA	-24.98%
RSI	38.14
RSI Monthly	35.98
RSI Weekly	28.08
Sharpe ratio	-1.1x
Sharpe Ratio3y	-0.95x
Sharpe Ratio5y	0.08x
Sortino ratio	-1.6
Sortino Ratio3y	-1.27
Sortino Ratio5y	0.29
Total Return	2.22%
Tr YTD	-38.5
Tr1m	-5.37%
Tr1w	-3.81%
Tr3m	-13.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,672,574%
Net Borrowing	-39,855,000
Shares Insiders	9.52%
Shares Out	41,459,793
Shares Qo Q	0%
Shares Yo Y	0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	17,923.8x
Bv Per Share	18.91
CAPEX	TWD -32.6M
Ch10y	-58.51
Ch1m	-5.37
Ch1w	-3.81
Ch1y	-53.82
Ch3m	-15.43
Ch3y	-67.94
Ch5y	-10.62
Ch6m	-25.8
Change	-2.35%
Change From Open	-2.35
Close	29.75
Days Gap	0
Depreciation Amortization	65,968,000
Dollar Volume	348,629.1
Earnings Date	2026-11-10
EBIT	TWD 19.7M
EBITDA	TWD 85.7M
EPS	TWD 0.41
F Score	7
FCF	TWD 78.4M
FCF EV Yield	6.35x
FCF Per Share	TWD 1.89
Financing CF	-39,855,000
Fiscal Year End	December
Founded	1,999
Graham Number	13.21232
Graham Upside	-54.52
Income Tax	TWD 3.9M
Investing CF	-32,313,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2026-06-30
Lynch Fair Value	TWD 2.05
Lynch Upside	-92.94
Ma150	35.99
Ma150ch	-19.28%
Ma20	29.73
Ma20ch	-2.28%
Net CF	41,030,000
Next Earnings Date	2026-11-10
Open	29.75
P FCF Ratio	15.37
P OCF Ratio	10.85
Payment Date	2026-07-30
Position In Range	0
Ppne	658,821,000
Price Date	2026-09-11
Price EBITDA	TWD 14.05
Ptbv Ratio	1.54
Relative Volume	0.66x
Revenue	664,935,000x
Tax By Revenue	0.59x
Tax Rate	18.63%
Tr6m	-24.2%
Volume	12,001
Z Score	3.36

TPEX/1796 (TPEX/1796)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/1796

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/1796 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/1796

Frequently asked questions